Pazopanib for the treatment of soft-tissue sarcoma

Código QR

Pazopanib for the treatment of soft-tissue sarcoma

Pierre Heudel,1 Philippe Cassier,1 Olfa Derbel,1 Armelle Dufresne,1 Pierre Meeus,2 Philippe Thiesse,3 Dominique Ranch&egrave;re-Vince,4 Jean Yves Blay,1 Isabelle Ray-Coquard1,51Department of Medical Oncology, 2Department of Surgical Oncology, 3Department of Radiology, 4Department of Patholog...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Heudel P, Cassier P, Derbel O, Dufresne A, Meeus P, Thiesse P, Ranch&egrave;re-Vince D, Blay JY, Ray-Coquard I
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/b1967181c70045e88f03c8d5e700d598
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Intra-Tumoral Pharmacokinetics of Pazopanib in Combination with Radiotherapy in Patients with Non-Metastatic Soft-Tissue Sarcoma
por: Laura Molenaar-Kuijsten, et al.
Publicado: (2021)

Does the Use of Peripheral Immune-Related Markers Indicate Whether to Administer Pazopanib, Trabectedin, or Eribulin to Advanced Soft Tissue Sarcoma Patients?
por: Eijiro Shimada, et al.
Publicado: (2021)

Different patterns of pneumothorax in patients with soft tissue tumors treated with pazopanib: A case series analysis.
por: Hisaki Aiba, et al.
Publicado: (2021)

Olaratumab: a platelet-derived growth factor receptor-α-blocking antibody for the treatment of soft tissue sarcoma
por: Pender A, et al.
Publicado: (2017)

Oncopig Soft-Tissue Sarcomas Recapitulate Key Transcriptional Features of Human Sarcomas
por: Kyle M. Schachtschneider, et al.
Publicado: (2017)

Targeting glutamine metabolism slows soft tissue sarcoma growth
por: Pearl Lee, et al.
Publicado: (2020)

Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial
por: Antoine Italiano, et al.
Publicado: (2021)

Predictive and prognostic transcriptomic biomarkers in soft tissue sarcomas
por: Eve Merry, et al.
Publicado: (2021)

Molecular targeted therapy for advanced or metastatic soft tissue sarcoma
por: Jin Yuan MD, et al.
Publicado: (2021)

Epigenetic re-expression of HIF-2α suppresses soft tissue sarcoma growth
por: Michael S. Nakazawa, et al.
Publicado: (2016)

GSK3-beta as a candidate therapeutic target in soft tissue sarcomas
por: S. Verbeke, et al.
Publicado: (2021)

WNT/β-Catenin Pathway in Soft Tissue Sarcomas: New Therapeutic Opportunities?
por: Esther Martinez-Font, et al.
Publicado: (2021)

Chronic hepatitis C: future treatment
por: Wendt A, et al.
Publicado: (2014)

A Successful Chemoembolization of a Retroperitoneal Soft Tissue Sarcoma: A Case Report
por: Waldec Jorge David Filho, et al.
Publicado: (2021)

Improving Immunotherapy Efficacy in Soft-Tissue Sarcomas: A Biomarker Driven and Histotype Tailored Review
por: Matthieu Roulleaux Dugage, et al.
Publicado: (2021)

Hypofractionated preoperative radiotherapy for high risk soft tissue sarcomas in a geriatric patient population
por: Potkrajcic Vlatko, et al.
Publicado: (2021)

A Novel Four-Gene Prognostic Signature for Prediction of Survival in Patients with Soft Tissue Sarcoma
por: Changwu Wu, et al.
Publicado: (2021)

Demographics, Changes in Treatment Patterns, and Outcomes of Bone and Soft Tissue Sarcomas in Korea—A Sarcoma-Specific, Institutional Registry-Based Analysis
por: Jeong H, et al.
Publicado: (2021)

Attenuation of soft-tissue sarcomas resistance to the cytotoxic action of TNF-α by restoring p53 function.
por: Jane Muret, et al.
Publicado: (2012)

Identification and Validation of a Novel Pyroptosis-Related Gene Signature for Prognosis Prediction in Soft Tissue Sarcoma
por: Lin Qi, et al.
Publicado: (2021)

A demographic and clinical panorama of a sixteen-year cohort of soft tissue sarcoma patients in Brazil
por: Luiza Ohasi de Figueiredo, et al.
Publicado: (2021)

Comparison of Different Systemic Therapeutic Regimes in Resectable Soft-Tissue Sarcoma—Results of a Network Meta-Analysis
por: Jan Haussmann, et al.
Publicado: (2021)

Identification and Validation of Pyroptosis-Related lncRNA Signature and Its Correlation with Immune Landscape in Soft Tissue Sarcomas
por: Lin Z, et al.
Publicado: (2021)

Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing.
por: Françoise Ducimetière, et al.
Publicado: (2011)

Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinoma
por: Peter E Clark
Publicado: (2010)

Diagnostic accuracy of ultrasound-guided core needle biopsy versus incisional biopsy in soft tissue sarcoma: an institutional experience
por: Miroslava Cernakova, et al.
Publicado: (2021)

Establishment of A Nomogram for Predicting the Prognosis of Soft Tissue Sarcoma Based on Seven Glycolysis-Related Gene Risk Score
por: Yuhang Liu, et al.
Publicado: (2021)

Greater travel distance to specialized facilities is associated with higher survival for patients with soft-tissue sarcoma: US nationwide patterns.
por: Tomohiro Fujiwara, et al.
Publicado: (2021)

Genome wide methylation profiling of selected matched soft tissue sarcomas identifies methylation changes in metastatic and recurrent disease
por: Ana Cristina Vargas, et al.
Publicado: (2021)

A DNA damage repair gene‐associated signature predicts responses of patients with advanced soft‐tissue sarcoma to treatment with trabectedin
por: David S. Moura, et al.
Publicado: (2021)

Doxorubicin/Adriamycin Monotherapy or Plus Ifosfamide in First-Line Treatment for Advanced Soft Tissue Sarcoma: A Pooled Analysis of Randomized Trials
por: Bi-Cheng Wang, et al.
Publicado: (2021)

Response to pazopanib‐based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma
por: Sewanti Limaye, et al.
Publicado: (2021)

ULTRASOUND DIAGNOSIS OF THE MASS IN THE SOFT TISSUES OF THE NECK OF THE CHILD
por: T. P. Lagunova, et al.
Publicado: (2015)

SIGNIFICANCE OF BLOOD INDICES IN DIFFERENTIAL DIAGNOSTICS OF STREPTOCOCCAL INFECTIONS OF SOFT TISSUES
por: A. P. Frolov
Publicado: (2012)

Imaging and Pathological Features of Alveolar Soft Part Sarcoma: Analysis of 16 Patients
por: Malvika Gulati, et al.
Publicado: (2021)

High expression of CD109 antigen regulates the phenotype of cancer stem-like cells/cancer-initiating cells in the novel epithelioid sarcoma cell line ESX and is related to poor prognosis of soft tissue sarcoma.
por: Makoto Emori, et al.
Publicado: (2013)

Clinical Outcome in Soft Tissue Sarcoma Patients with Lung Metastasis Who Received Metastasectomy and/or Radiofrequency Ablation: Tokai Musculoskeletal Oncology Consortium Study
por: Nakamura T, et al.
Publicado: (2021)

Editorial: Adipose Tissue in the Cardiovascular Homeostasis and Disease
por: Joshua T. Butcher, et al.
Publicado: (2021)

Eribulin activity in soft tissue sarcoma monolayer and three-dimensional cell line models: could the combination with other drugs improve its antitumoral effect?
por: Javier Escudero, et al.
Publicado: (2021)

Accuracy and Safety of Ultrasound-Guided Core Needle Biopsy of Soft Tissue Tumors in an Outpatient Setting: A Sarcoma Center Analysis of 392 Consecutive Patients
por: Helene Weigl, et al.
Publicado: (2021)